País: Reino Unido
Idioma: inglés
Fuente: MHRA (Medicines & Healthcare Products Regulatory Agency)
Citalopram hydrobromide
Zentiva Pharma UK Ltd
N06AB04
Citalopram hydrobromide
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030300; GTIN: 5000283630159
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CITALOPRAM 10MG, 20MG AND 40MG FILM-COATED TABLETS IMPORTANT THINGS YOU NEED TO KNOW ABOUT CITALOPRAM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Citalopram treats depression and panic disorders but it will not work straight away. Like all medicines, it can have side-effects. It is IMPORTANT that you and your doctor talk about the benefits and the possible unwanted effects of the medicine before you start taking it. • Citalopram should not be taken by children or teenagers under 18 (see section 6). • Citalopram will not work straight away. You may feel worse before feeling better after starting the medicine. Your doctor should ask to see you again 2 or 3 weeks after you first start taking the medicine. Tell your doctor if you feel no better (see section 3). • You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour (see section 2). • If you feel restless or feel like you cannot keep still, go to your doctor. If you keep on taking more citalopram each day, it may make these feelings worse (see section 5). • Talk to your doctor before you stop taking citalopram. If you stop taking it suddenly or miss a dose you may get unwanted effects (see section 4). • Taking some other medicines with citalopram can cause problems. You may need to talk to your doctor first (see section 2). • If you are pregnant or planning to get pregnant, talk to your doctor before taking citalopram (see section 2). READ THE REST OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medici Leer el documento completo
1 NAME OF THE MEDICINAL PRODUCT Citalopram 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg citalopram (as hydrobromide) For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet White, 6mm round, biconvex tablets 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Treating depression _ _Adults:_ Citalopram should be administered as a single oral dose of 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily. In general, improvement in patients starts after 1 week, but may only become evident from the second week of therapy. As with all antidepressant medicinal products, dosage should be reviewed and adjusted, if necessary, within 3 - 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be an increased potential for undesirable effects at higher doses, if after some weeks on the recommended dose insufficient response is seen, some patients may benefit from having their dose increased up to a maximum of 40 mg a day (see section 5.1). Dosage adjustments should be made carefully on an individual patient basis, to maintain the patient at the lowest effective dose. Patients with depression should be treated for a sufficient period of at least six months to ensure that they are free from symptoms. _Treating panic disorder_ _Adults: _ A single oral dose of 10 mg is recommended for the first week before increasing the dose to 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily. Patients should be started on 10 mg/day and the dose gradually increased in 10 mg steps according to the patient's response up to the recommended dose. A low initial starting Leer el documento completo